Muscarinic agonists and antagonists in schizophrenia: Recent therapeutic advances and future directions

Amanda R. Bolbecker, Anantha Shekhar

Research output: Chapter in Book/Report/Conference proceedingChapter

8 Scopus citations

Abstract

Existing therapies for schizophrenia have limited efficacy, and significant residual positive, negative, and cognitive symptoms remain in many individuals with the disorder even after treatment with the current arsenal of antipsychotic drugs. Preclinical and clinical data suggest that selective activation of the muscarinic cholinergic system may represent novel therapeutic mechanisms for the treatment of schizophrenia. The therapeutic relevance of earlier muscarinic agonists was limited by their lack of receptor selectivity and adverse event profile arising from activation of nontarget muscarinic receptors. Recent advances in developing compounds that are selective to muscarinic receptor subtypes or activate allosteric receptor sites offer tremendous promise for therapeutic targeting of specific muscarinic receptor subtypes in schizophrenia.

Original languageEnglish (US)
Title of host publicationMuscarinic Receptors
EditorsAllison D. Fryer, Neil M. Nathanson, Arthur Christopoulos
Pages167-190
Number of pages24
DOIs
StatePublished - Feb 10 2012

Publication series

NameHandbook of Experimental Pharmacology
Volume208
ISSN (Print)0171-2004
ISSN (Electronic)1865-0325

Keywords

  • Acetylcholine
  • Allosteric
  • Cholinergic
  • Cognitive
  • Muscarinic
  • Psychosis
  • Schizophrenia

ASJC Scopus subject areas

  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Biochemistry

Fingerprint Dive into the research topics of 'Muscarinic agonists and antagonists in schizophrenia: Recent therapeutic advances and future directions'. Together they form a unique fingerprint.

  • Cite this

    Bolbecker, A. R., & Shekhar, A. (2012). Muscarinic agonists and antagonists in schizophrenia: Recent therapeutic advances and future directions. In A. D. Fryer, N. M. Nathanson, & A. Christopoulos (Eds.), Muscarinic Receptors (pp. 167-190). (Handbook of Experimental Pharmacology; Vol. 208). https://doi.org/10.1007/978-3-642-23274-9_8